Compare Dolby Laboratories, Inc. (DLB) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Raymond James Financial, Inc. — how do they compare? Dolby Laboratories, Inc. trades at $58.9 (market cap $5.47B), while Raymond James Financial, Inc. trades at $158.14 (market cap $30.51B). The key difference: Raymond James Financial, Inc. is far larger — about 5.6× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Raymond James Financial, Inc. for 74 Days on average.
| DLB | RJF | |
|---|---|---|
Market Cap | $5.47B | $30.51B |
Volume | 1,058,284 | 1,206,253 |
Sector | Technology | Financials |
52-Week High | $70.09 | $181.18 |
52-Week Low | $48.51 | $140.89 |
Typical Hold Time | 98 Days | 74 Days |
Enterprise Value | $4.85B | $24.37B |
Dividend Yield | 2.46% | 1.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals. The company maintains strong profitability with 87.61% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten. Cash flow improved significantly in 2025 with $472M operating cash flow.
DLB presents a mixed outlook with strong fundamentals but technical weakness. The 47% upside to $90.33 consensus target offers potential, though near-term execution risks and licensing volatility remain concerns. Revenue stability around $1.3B and premium valuation metrics require continued innovation execution to justify current multiples.
Raymond James Financial (RJF) trades at $157.29, down 1.4% with a bearish technical signal. The company shows strong fundamentals with consistent earnings beats, 15.4% net margin, and 18.5% ROE. Recent Q3 2026 results featured record revenues of $3.93 billion, beating estimates. Analysts maintain a Hold consensus with $184 price target, representing 17% upside potential from current levels.
RJF presents a mixed outlook with strong operational performance offset by technical weakness. The stock offers value at 13.7x P/E with dividend growth potential, but faces headwinds from rising expenses and market volatility. Institutional activity shows mixed signals with both position increases and decreases among major holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
